about
Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistryRelationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreasNeurofunctional imaging of β-cell dynamicsMapping the target localization and biodistribution of non-radiolabeled VMAT2 ligands in rat brain.In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrationsPET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133)Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease.Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligandsPharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transportersNon-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degenerationQuantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and WithdrawalRapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studiesBrain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.
P2860
Q24601233-CBDB254A-C340-4A5A-98D5-213AEC50B8B5Q24653211-9B1625C5-50E2-4284-BF21-5461F1571FD8Q26829645-09098498-7252-4ED7-84CB-60C98494E6E1Q33574108-80E67EAB-BCBD-40AA-8418-EB28992BF2ECQ33636269-D8E7A0A7-B02E-4A14-AF91-5ED3B2B8A53EQ34314094-4F13F075-CE1D-4325-B632-911AFAF63A3AQ34673305-61B6B899-553A-4AC1-AF8C-C83840548F0AQ34974523-AF8B30A4-AB05-4F37-A8EA-CFDC277628F7Q35651214-7474147A-B189-4D6C-9C2F-C7EF6F49C63FQ35867486-A5820A64-F23B-49B4-95E1-434749961A9BQ35891436-B3956CAA-A4E4-46A8-8A3D-0BCA83B9D34CQ36103817-B8FAE460-E6F3-48D8-BB64-4E13F9D69F83Q36296658-5BA64B9C-CBDA-49B4-B234-A19F997C1CADQ36460012-ED831428-DE90-4DB7-9C65-D24FB81D86B3Q36565693-EB905258-5B3A-45DE-A554-CF1D9ED7AC99Q37056546-231A3729-12CB-4438-BBB3-0DCB03E48A4DQ37105104-ACCA52B0-C968-46FE-A4E8-99C463D8759FQ38926228-62FFB0AA-A8BA-4030-BE58-867D5A4465BE
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Imaging the vesicular monoamine transporter.
@ast
Imaging the vesicular monoamine transporter.
@en
Imaging the vesicular monoamine transporter.
@nl
type
label
Imaging the vesicular monoamine transporter.
@ast
Imaging the vesicular monoamine transporter.
@en
Imaging the vesicular monoamine transporter.
@nl
prefLabel
Imaging the vesicular monoamine transporter.
@ast
Imaging the vesicular monoamine transporter.
@en
Imaging the vesicular monoamine transporter.
@nl
P2093
P1476
Imaging the vesicular monoamine transporter.
@en
P2093
P304
P577
2001-01-01T00:00:00Z